Gilead Sciences (NASDAQ: GILD) last traded at $147.92, down 1.67% on the session. The quote above updates while this page is open; the figures below are drawn from Gilead Sciences’s own filings and are restated only when a new one is published.
Gilead Sciences trades on NASDAQ under the ticker GILD. It is classified in the Healthcare sector, Biotech industry. Its market capitalisation is $183.41 billion.
Healthcare sectorBiotechListed on NASDAQ
Valuation measures for Gilead Sciences, derived from the latest quote and its most recent SEC filing.
| Market cap | $183.41B |
|---|---|
| Enterprise value | $217.85B |
| Price / sales | 6.02 |
| Price / book | 15.51 |
| Beta |
|---|
| 0.36 |
Trailing-twelve-month figures tagged in Gilead Sciences's XBRL filings with the SEC.
| Revenue (TTM) | $30.46B |
|---|---|
| Net income (TTM) | -$3.24B |
| EPS (TTM) | -$2.66 |
| Gross margin | 79.59% |
| Operating margin | -8.20% |
| Return on equity | -27.39% |
| Cash | $3.18B |
Range and volume for GILD over the past 52 weeks.
| 52-week high | $157.29 |
|---|---|
| 52-week low | $114.02 |
| Volume | 5.56M |
| Average volume | 5.99M |
| Previous close | $150.43 |
Dividend history for Gilead Sciences over the trailing twelve months.
| Dividend yield | 2.18% |
|---|---|
| Dividend per share (TTM) | $3.22 |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Gilead Sciences with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GILD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.